A phase2 trial ofAbraxane Oxaliplatin S1 and Itraconazole for unresectable gastric cancer
Phase 2
- Conditions
- nresectable gastric cancer
- Registration Number
- JPRN-UMIN000021340
- Lead Sponsor
- Meiwa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Severe complication Favor up over 38.0 degree Diarrhea over four times in a day Clinical problem for each patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Overall survival, Progression free survival, Disease conctrol rate, adverse event